NEW YORK, April 17- LifeSpan Biosciences has raised $19 million in a third round of private financing, the company said Tuesday.

LifeSpan of Seattle, plans to use the new funds to automate and enhance its high-throughput gene expression analysis technology, launch new disease and gene family databases, including a cancer database, and fortify its gene research programs.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.